300016 北陸藥業
按盤價 
5.560 +0.180 (+3.346%)
5.560 +0.180 (+3.346%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.176 | -4.188 | 0.621 | 6.975 | 10.945 |
| 總資產報酬率 ROA (%) | 0.664 | -2.545 | 0.394 | 4.364 | 7.814 |
| 投入資產回報率 ROIC (%) | 0.741 | -2.826 | 0.443 | 4.958 | 8.743 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.713 | 47.008 | 55.390 | 62.270 | 66.581 |
| 營業利潤率 (%) | 4.347 | -11.276 | -1.734 | 14.789 | 22.135 |
| 息稅前利潤/營業總收入 (%) | 9.538 | -6.388 | 3.554 | 17.415 | 20.323 |
| 淨利潤/營業總收入 (%) | 3.207 | -9.341 | -0.594 | 12.826 | 18.613 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 107.027 | 56.298 | 165.688 | 71.042 | 84.777 |
| 價值變動淨收益/利潤總額(%) | -25.090 | 7.873 | -139.154 | 22.088 | 14.422 |
| 營業外收支淨額/利潤總額(%) | -0.811 | 0.708 | 10.020 | -3.938 | -5.344 | 償債能力分析 |
| 流動比率 (X) | 2.510 | 3.332 | 3.892 | 4.574 | 3.933 |
| 速動比率 (X) | 1.898 | 2.650 | 2.979 | 3.698 | 3.592 |
| 資產負債率 (%) | 39.930 | 36.643 | 31.766 | 28.173 | 0.336 |
| 帶息債務/全部投入資本 (%) | 35.763 | 31.748 | 27.091 | 24.883 | 28.427 |
| 股東權益/帶息債務 (%) | 170.704 | 204.874 | 258.021 | 292.957 | 243.554 |
| 股東權益/負債合計 (%) | 136.513 | 159.771 | 198.395 | 226.957 | 182.303 |
| 利息保障倍數 (X) | 1.825 | -1.285 | 0.648 | 5.466 | -29.492 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 69.908 | 58.856 | 56.390 | 63.644 | 71.717 |
| 存貨周轉天數 (天) | 213.588 | 198.714 | 277.242 | 203.681 | 155.894 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
